Use of direct observed therapy to confirm compliance in a warfarin clinic

Rhonda Deen1

  • 1Department of Primary Care, Irwin Army Community Hospital, Fort Riley, Kansas, USA. Rhonda.deen@us.army.mil

Journal of Patient Safety
|November 9, 2011
PubMed

Insights

Direct observed therapy (DOT) can improve warfarin management by confirming patient compliance. This method provides objective data for medication adjustments, enhancing patient safety in anticoagulation clinics.

Area of Science:

  • Pharmacology
  • Patient Adherence
  • Clinical Management

Background:

  • Anticoagulation therapy, particularly warfarin, carries significant risks and healthcare costs.
  • Warfarin clinics reduce complications, but patient compliance remains a challenge.
  • Current methods for assessing compliance in warfarin clinics are limited.

Purpose of the Study:

  • To evaluate the feasibility and utility of direct observed therapy (DOT) for managing patients on warfarin.
  • To determine if DOT can provide objective data on medication compliance.
  • To explore how DOT can improve patient safety and treatment efficacy in anticoagulation management.

Main Methods:

  • Implementation of a short course of direct observed therapy (DOT) in a warfarin clinic setting.
  • Monitoring patient adherence to prescribed anticoagulation medication through direct observation.
  • Collecting data on patient compliance and comparing it with self-reported adherence.

Main Results:

  • Direct observed therapy (DOT) proved to be a feasible method for confirming anticoagulation medication compliance.
  • DOT provided objective data, enabling providers to adjust warfarin dosage based on confirmed adherence rather than patient self-reporting.
  • The technique allowed for direct confrontation of noncompliance with tangible evidence.

Conclusions:

  • Direct observed therapy (DOT) is an effective strategy for warfarin clinics to address patient compliance issues.
  • Utilizing DOT enhances the ability of healthcare providers to safely manage patients on anticoagulation therapy.
  • This approach facilitates data-driven medication adjustments and improves overall patient outcomes in anticoagulation management.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...